Infinity Pharmaceuticals, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (34)

Latest Posts

About This Stock More About This Stock
5 Best Biotech Stocks To Buy In October
Article By: Zacks Investment Research
Monday, October 1, 2018 11:50 AM EDT
Here are five stocks that are expected to move north following successful drug developments.
In this article: CSBR, CYDY, INFI, NKTR, ZTS Also: AMRN, ACAD, SRPT, GILD, AGN
Read
Wells Fargo Says Buy Micro-Cap Drugmaker Ahead Of Cancer Immunotherapy Meeting
Article By: The Fly
Thursday, October 12, 2017 12:31 PM EDT
Shares of Infinity Pharmaceuticals are on the rise after Wells Fargo analyst Jim Birchenough upgraded the stock to a buy-equivalent rating.
In this article: INFI Also: FPRX
Read
Small Cap Best & Worst Stocks - March 31, 2016
Article By: E.B. Capital Markets
Thursday, March 31, 2016 8:18 AM EDT
The average small cap score is 51.16 and that's below the four week average score of 52.54.
In this article: BYD, ELLI, MOV, STRI, ABMD, DWSN, INFI, NVAX, REDF, ANIK, CCRN, FRAN, OFIX, SONC, MTSI
Read
Small Cap Best & Worst Stocks - March 17, 2016
Article By: E.B. Capital Markets
Thursday, March 17, 2016 9:40 AM EDT
The average small cap score is 51.38, which is above the four week score of 51.31. The average small cap stock in our universe is trading -35.7% below its 52 week high, -4.37% below its 200 dma, and has 7.31 days to cover held short.
In this article: ELLI, GTS, STRI, ABTL, AVAV, INFI, REDF, CECO, OFIX, PRSC, QLTI, SNHY, DVAX, MTSI
Read
Capture Growth With Baskets Of Biotechs: LifeSci Advisors' Andrew McDonald
Article By: The Life Sciences Report
Friday, February 13, 2015 7:37 PM EDT
In this interview, Andrew McDonald describes how funds can be designed to grow on product sales and data generated via milestones in clinical development, and also names four companies he's included in the two portfolios.
In this article: GSK, CYTK, BBC, BBP, IBB, PCYC, JNJ, CELG, NVS, IDRA, PRTA, INFI, ABBV
Read

Latest Tweets for $INFI

No tweets yet!

PARTNER HEADLINES